By opening up its voice-activated assistant to developers, Amazon thinks it can sell more of its Web services to device makers.
The search giant is once again pushing the innovation envelope, but it may be spot on this time around.
Juno Therapeutics saw its shares rise by 33% today. Here's why.
AbbVie and Johnson & Johnson are widely recognized as top-tier dividend stocks. Here is a look at which one offers the better long-term prospects for income-seeking investors.
A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.
After launching on Echo, Amazon wants to bring its virtual assistant Alexa to the masses.
Tracing Bank of America's history through the three biggest banking crises of the past century.
Let's take advantage of the calm before the earnings storm to put together your earnings checklist.
Fantasy films are some of the biggest cash machines in Hollywood. Should Netflix or Amazon grab a license for this classic fantasy book series?
Big Blue is continuing its plans of aligning itself with strategic partners to help its move up the list of cloud sales leaders.